West Bancorporation Inc Gilead Sciences, Inc. Transaction History

West Bancorporation Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $4,217 - $4,786	-65 Reduced 49.62%	66 $5,000
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $99,105 - $115,080	-1,370 Reduced 91.27%	131 $10,000
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $7,390 - $9,465	-118 Reduced 7.29%	1,501 $112,000
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $99,762 - $109,735	1,619 New	1,619 $105,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of West Bancorporation Inc, based on Form 13F filings with the SEC.

Stay updated on West Bancorporation Inc with notifications on news.